Pharmaceutical Technology

JANUARY 20, 2023

In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. billion in Covid-19 vaccine sales.

Vaccines 98

Vaccines Communication FDA 98

Hospital Pharmacy Europe

JANUARY 6, 2025

Developments such as mRNA cancer vaccines , pharmacogenomics and personalised medicine are going to be transformative for the sector, Professor Meier says. And he draws a parallel to the Covid-19 pandemic when pharmacists played a central role when carrying out vaccinations, even in countries where this was previously unprecedented.

Community Pharmacies 98

Community Pharmacies Vaccines Hospitals Documentation 98

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And those volumes will only increase.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 111

Pharma Marketing Network

JANUARY 7, 2025

Because the way your company communicates its value to patients, healthcare providers, and stakeholders can mean the difference between success and failure. This article explores top strategies that can help you lead with confidence and achieve executive success in 2025. Why does this matter?

Communication 52

Communication FDA Patient Care Vaccines 52

Hospital Pharmacy Europe

MARCH 13, 2025

Timely follow-up after hospital attendance and communication at transfers of care is therefore imperative Identifying patients through targeted searching of primary care databases is expected to be a way to review prescribing and revisit diagnosis. Accessed February 2025]. Accessed February 2025]. Accessed February 2025].

Hospitals 52

Hospitals Labelling Communication Patient Care 52

European Pharmaceutical Review

SEPTEMBER 29, 2023

of the draft revised Community Code provides a reduction in the basic data exclusivity period for innovative medicinal products from eight to six years, a revision which did not come as a great surprise to many. As an example, Article 81.1 The European Commission has evidently expended significant effort in developing the proposals.

Communication 98

Communication Hospitals Vaccines 98

ISPE

OCTOBER 26, 2022

Reintroducing the liaison role of International Board members with individual Chapters and Affiliates has given us direct lines of communication to the mutual benefit of the International Board and the local groups. We defined the path forward for 2023–2025 after a final round of consultations with the Board advisors in July.

Packaging 52

Packaging Compounding Communication Vaccines 52

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. The approval of the mRNA Covid-19 vaccine, which is a biologic, has thrust the modality even further into the spotlight.

Vaccines 52

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

SEPTEMBER 11, 2023

Nature Communications 12, no. Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” www.fiercepharma.com/manufacturing/sanofi-pumps-554m-into-new-vaccine-manufacturing-facility-eastern-france 41 Boccard. New Project: Evolutive Vaccines Facility for Sanofi.” Biotechnology Progress 36, no.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

Pharmaceutical Technology

MARCH 22, 2023

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Hospital Pharmacy Europe

MARCH 13, 2025

Timely follow-up after hospital attendance and communication at transfers of care is therefore imperative Identifying patients through targeted searching of primary care databases is expected to be a way to review prescribing and revisit diagnosis. Accessed February 2025]. Accessed February 2025]. Accessed February 2025].

Hospitals 52

Hospitals Labelling Communication Patient Care 52